Adjuvant radiation versus observation: A cost analysis of alternate management schemes in early-stage testicular seminoma

Journal of Clinical Oncology

Volumn 14, Issue 11, 1996, Pages 2933-2939

  Sharda, N N ^a   Kinsella, T J ^a   Ritter, M A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; PLATINUM; TUMOR MARKER;

ALGORITHM; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; FOLLOW UP; HEALTH CARE COST; HOSPITAL BILLING; HUMAN; MALE; OBSERVATION; ORCHIECTOMY; POLICY; PRIORITY JOURNAL; REIMBURSEMENT; SEMINOMA; TREATMENT OUTCOME; TUMOR RECURRENCE;

EID: 0029842644     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.11.2933     Document Type: Article

References (25)

1. Warde P, Gospodarowicz MK, Panzarella T, et al: Stage I testicular seminoma: Results of adjuvant irradiation and surveillance. J Clin Oncol 9:2255-2262, 1995
2. Zagars GK, Babaian RJ: Stage I testicular seminoma: Rationale for postorchiectomy radiation therapy. Int J Radial Oncol Biol Phys 13:163-170, 1987
3. Hamilton C, Horwich A, Easton D, et al: Radiotherapy for stage I seminoma testis: Results of treatment and complications. Radiother Oncol 6:115-120, 1986
4. Giacchetti S, Raoul Y, Wibault P, et al: Treatment of stage I testis seminoma by radiotherapy: Long term results - a 30-year experience. Int J Radiat Oncol Biol Phys 27:3-9, 1993
5. von der Maase H, Specht L, Jacobsen GK, et al: Surveillance following orchidectomy for stage I seminoma of the testis. Eur J Cancer 29A: 1931 -1934, 1993
6. Germa Lluch JR, Climent MA. Villavicencio H, et al: Treatment of stage I testicular tumors. Br J Urol 71:473-477, 1993
7. Duchesne GM, Horwich A, Dearnaley DP, et al: Orchidectomy alone for stage I seminoma of the testis. Cancer 65:1115-1118, 1990
8. Parker SL, Tong T, Bolden S, et al: Cancer statistics, 1996. CA Cancer J Clin 46:1, 1996
9. Drummond MF, Stoddart GL, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes. Oxford, United Kingdom, Oxford University Press, 1994
10. Jonsson B, Karlsson G: Outcome measurement in economic evaluations of growth factors. Eur J Cancer 29A:S19-S22, 1993 (suppl)
11. Einhorn LH: Treatment of testicular cancer: A new and improved model. J Clin Oncol 11:1777-1781, 1990
12. Williams SD, Birch R, Einhorn LH, et al: Treatment of disseminated germ-cell tumors with cisplatin, bleomycin and either vinblastine or etoposide. N Engl J Med 316:1435-1440, 1987
13. Williams SD, Roth BJ: Chemotherapy of testis cancer. Int J Radiat Oncol Biol Phys 22:213-217, 1991
14. Shibley L, Brown M, Schuttinga J, et al: Cisplatin-based combination chemotherapy in the treatment of advanced-stage testicular cancer: Cost-benefit analysis. J Natl Cancer Inst 82:186-192, 1990
15. Hanks GE, Peters T, Owen J: Seminoma of the testis: Long term beneficial and deleterious results of radiation. Int J Radiat Oncol Biol Phys 24:913-919, 1992
16. Kleinerman RA, Lieberman JV, Li FP: Second cancer following cancer of the male genital system in Connecticut, 1935-82. NCI Monogr 68:139-147, 1985
17. van Leeuwen FE, Stiggelbout AM, van den Belt-Dusebout AW, et al: Second cancer risk following testicular cancer: A followup study of 1,909 patients. J Clin Oncol 11:415-424, 1993
18. Kaldor M, Day NE, Band P, et al: Second malignancies following testicular cancer, ovarian cancer and Hodgkins disease: An international collaborative study among cancer registries. Int J Cancer 39:571-585, 1987
19. Moller H, Mellemgaard A, Jacobsen GK, et al: Incidence of second primary cancer following testicular cancer. Eur J Cancer 29A:672-676, 1993
20. Fossa SD, Langmark F, Aass N, et al: Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy. Br J Cancer 61:639-643, 1990
21. Kubo H, Shipley WU: Reduction of the scatter dose to the testicle outside the radiation treatment fields. Int J Radiat Oncol Biol Phys 8:1741-1745, 1982
22. Fraass BA, Kinsella TJ, Harrington FS, et al: Peripheral dose to the testis: The design and clinical use of a practical and effective gonadal shield. Int J Radiat Oncol Biol Phys 11:609-615, 1985
23. Kinsella TJ, Trivette G, Rowland J, et al: Long-term followup of testicular function following radiation therapy for early-stage Hodgkins disease. J Clin Oncol 6:718-724, 1989
24. Glaspy JA, Bleeker G, Crawford J, et al: The impact of therapy with filgrastim (recombinant granulocyte colony-stimulating factor) on the health care costs associated with cancer chemotherapy. Eur J Cancer 29A:S23-30, 1993 (suppl)
25. Leese B: The costs of treating febrile neutropenia in six U.K. hospitals. Eur J Cancer 29A:S15-18, 1993 (suppl)